查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1637090

解剖病理学市场 - 全球产业分析、规模、占有率、成长、趋势及2032年预测

Anatomic Pathology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
出版日期: | 出版商: Fairfield Market Research | 英文 195 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球解剖病理学市场规模预计将大幅扩大，预估2025年至2032年期间年复合成长率为 7.9%。随着诊断技术的进步、慢性病盛行率的上升以及老年人口的不断成长，市场规模预计将从2025年的40.7亿美元扩大到2032年底的69.3亿美元。

解剖病理学是病理学的一个重要分支，包括在显微镜下研究组织和细胞以识别疾病。此领域结合组织病理学、细胞学和免疫组织化学等技术来分析组织的结构和功能变化。它在指导治疗方法、预测患者结果和提高对各种疾病的理解方面发挥关键作用。随着医疗保健领域随着新技术和人口结构的变化而发展，解剖病理学仍然是诊断和治疗决策的基石。

影像、分子病理学和自动化方面的重大进步提高诊断的准确性和效率。数位病理学的采用实现了幻灯片数位化、远端协作和人工智慧驱动的分析，实现更快、更准确的诊断。

本报告调查全球解剖病理学市场，提供市场概述，依产品/服务、应用、最终用途、地理的趋势，和参与市场的公司的竞争趋势。

目录

第1章 执行摘要

第2章 市场概览

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • COVID-19 影响分析
  • 乌克兰与俄罗斯衝突的影响
  • 经济概况
  • PESTLE 分析

第3章 全球解剖病理学市场展望，2019年～2032年

  • 2019年至2032年全球解剖病理学市场预测（依产品/服务、价值（十亿美元））
  • 2019年至2032年全球解剖病理学市场应用预测、价值（十亿美元）
  • 2019年至2032年全球解剖病理学市场预测（依最终用途、价值（十亿美元））
  • 2019年至2032年全球解剖病理学市场预测（依地区划分）价值（十亿美元）

第4章 北美解剖病理学市场展望，2019年～2032年

第5章 欧洲解剖病理学市场展望，2019年～2032年

第6章 亚太地区解剖病理学市场展望，2019年～2032年

第7章 拉丁美洲解剖病理学市场展望，2019年～2032年

第8章 中东和非洲解剖病理学市场展望，2019年～2032年

第9章 竞争格局

  • 2025年公司市场占有率分析
  • 竞争资讯中心
  • 公司简介
    • BioGenex
    • Cardinal Health, Inc.
    • Sakura Finetek USA, Inc.
    • Quest Diagnostics Incorporated
    • Agilent Technologies
    • Bio SB
    • F. Hoffmann-La Roche AG
    • NeoGenomics
    • Laboratory Corporation of America Holdings

第10章 附录

简介目录

The global anatomic pathology market is poised for substantial expansion, projected to grow at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032. The market size is anticipated to rise from US$4.07 billion in 2025 to US$6.93 billion by the end of 2032, driven by technological advancements in diagnostics, increasing prevalence of chronic diseases, and a growing elderly population.

Understanding Anatomic Pathology

Anatomic pathology is a crucial discipline within pathology that involves the microscopic study of tissues and cells for disease identification. This field incorporates techniques such as histopathology, cytology, and immunohistochemistry to analyze structural and functional changes in tissues. It plays an essential role in guiding treatment approaches, predicting patient prognoses, and deepening the understanding of various diseases. As the healthcare sector evolves with new technologies and demographic shifts, anatomic pathology remains a cornerstone of diagnostic and therapeutic decision-making.

Market Insights

Key Drivers of Growth:

1.Innovations in Diagnostic Technologies:

  • Significant progress in imaging, molecular pathology, and automation has led to improved diagnostic precision and efficiency.
  • The adoption of digital pathology allows for slide digitization, remote collaboration, and AI-driven analysis, enabling faster and more accurate diagnoses.

2.Increasing Disease Burden:

  • The rising prevalence of cancer and other chronic conditions is fueling demand for precise and timely pathology services.
  • A growing aging population, more vulnerable to health issues, is further accelerating market growth.

Challenges Impacting the Market:

1.Telepathology Implementation and Regulatory Complexities:

  • While remote diagnostics and collaborative pathology offer numerous benefits, diverse regulatory requirements related to data privacy and diagnostic accuracy pose challenges.

2.Barriers to Technological Integration:

  • High costs, interoperability concerns, and the need for specialized staff training make the transition from conventional pathology to digital platforms more complex.

Business Opportunities

Advancements in Diagnostic Solutions:

  • The integration of digital pathology, AI, and molecular diagnostic techniques enhances diagnostic precision and operational efficiency.
  • AI-driven algorithms expedite data interpretation, generating actionable insights and reducing turnaround times.

Strategic Research Collaborations:

  • Partnerships between pathology labs, research institutions, and pharmaceutical firms drive innovation in diagnostic methodologies.
  • Collaborative efforts in biomarker discovery and companion diagnostics contribute to the growth of personalized medicine.

Regional Outlook

North America:

  • Leads the global market with a well-developed healthcare system, widespread disease awareness, and substantial investment in diagnostic technologies.
  • The U.S. has recorded a 24.3% increase in the adoption of advanced pathology services over the past three years, reinforcing market expansion.

Europe:

  • Pioneers in implementing advanced diagnostic technologies, with strong backing from research collaborations.
  • Nations like the UK emphasize sustainability and standardized pathology procedures, cementing Europe's position as a significant market player.

South Asia & Pacific:

  • Emerging as the fastest-growing region, driven by the rapid enhancement of healthcare infrastructure and rising disease prevalence.
  • Greater awareness of preventive healthcare practices is boosting demand for pathology services.

Latin America and Middle East & Africa:

  • These regions are experiencing steady growth due to improved healthcare accessibility and expanding diagnostic capabilities.

Competitive Landscape

Leading Market Players:

  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Sakura Finetek USA, Inc.
  • F. Hoffmann-La Roche AG
  • Cardinal Health, Inc.
  • BioGenex
  • NeoGenomics
  • Bio SB
  • Agilent Technologies

Market Segmentation

By Product and Service:

  • Anatomic Pathology Instruments
  • Anatomic Pathology Consumables
  • Anatomic Pathology Services

By Application:

  • Disease Diagnosis
  • Drug Discovery and Development
  • Other Applications

By End-User:

  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Other Facilities

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Anatomic Pathology Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2025
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Anatomic Pathology Market Outlook, 2019 - 2032

  • 3.1. Global Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
    • 3.1.1. Key Highlights
      • 3.1.1.1. Anatomic Pathology Instruments
      • 3.1.1.2. Anatomic Pathology Consumables
      • 3.1.1.3. Anatomic Pathology Services
  • 3.2. Global Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
    • 3.2.1. Key Highlights
      • 3.2.1.1. Disease Diagnosis
      • 3.2.1.2. Drug Discovery and Development
      • 3.2.1.3. Others
  • 3.3. Global Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals
      • 3.3.1.2. Research Laboratories
      • 3.3.1.3. Diagnostic Laboratories
      • 3.3.1.4. Others
  • 3.4. Global Anatomic Pathology Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Anatomic Pathology Market Outlook, 2019 - 2032

  • 4.1. North America Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Anatomic Pathology Instruments
      • 4.1.1.2. Anatomic Pathology Consumables
      • 4.1.1.3. Anatomic Pathology Services
  • 4.2. North America Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Disease Diagnosis
      • 4.2.1.2. Drug Discovery and Development
      • 4.2.1.3. Others
  • 4.3. North America Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Research Laboratories
      • 4.3.1.3. Diagnostic Laboratories
      • 4.3.1.4. Others
  • 4.4. North America Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 4.4.1.2. Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 4.4.1.3. Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 4.4.1.4. Canada Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 4.4.1.5. Canada Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 4.4.1.6. Canada Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Anatomic Pathology Market Outlook, 2019 - 2032

  • 5.1. Europe Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Anatomic Pathology Instruments
      • 5.1.1.2. Anatomic Pathology Consumables
      • 5.1.1.3. Anatomic Pathology Services
  • 5.2. Europe Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Disease Diagnosis
      • 5.2.1.2. Drug Discovery and Development
      • 5.2.1.3. Others
  • 5.3. Europe Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Research Laboratories
      • 5.3.1.3. Diagnostic Laboratories
      • 5.3.1.4. Others
  • 5.4. Europe Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 5.4.1.2. Germany Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.3. Germany Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.4. U.K. Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 5.4.1.5. U.K. Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.6. U.K. Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.7. France Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 5.4.1.8. France Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.9. France Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.10. Italy Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 5.4.1.11. Italy Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.12. Italy Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.13. Turkey Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 5.4.1.14. Turkey Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.15. Turkey Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.16. Russia Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 5.4.1.17. Russia Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.18. Russia Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.19. Rest of Europe Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 5.4.1.20. Rest of Europe Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.21. Rest of Europe Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Anatomic Pathology Market Outlook, 2019 - 2032

  • 6.1. Asia Pacific Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Anatomic Pathology Instruments
      • 6.1.1.2. Anatomic Pathology Consumables
      • 6.1.1.3. Anatomic Pathology Services
  • 6.2. Asia Pacific Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Disease Diagnosis
      • 6.2.1.2. Drug Discovery and Development
      • 6.2.1.3. Others
  • 6.3. Asia Pacific Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Research Laboratories
      • 6.3.1.3. Diagnostic Laboratories
      • 6.3.1.4. Others
  • 6.4. Asia Pacific Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 6.4.1.2. China Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.3. China Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.4. Japan Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 6.4.1.5. Japan Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.6. Japan Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.7. South Korea Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 6.4.1.8. South Korea Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.9. South Korea Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.10. India Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 6.4.1.11. India Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.12. India Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.13. Southeast Asia Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 6.4.1.14. Southeast Asia Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.15. Southeast Asia Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.16. Rest of Asia Pacific Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 6.4.1.17. Rest of Asia Pacific Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.18. Rest of Asia Pacific Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Anatomic Pathology Market Outlook, 2019 - 2032

  • 7.1. Latin America Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Anatomic Pathology Instruments
      • 7.1.1.2. Anatomic Pathology Consumables
      • 7.1.1.3. Anatomic Pathology Services
  • 7.2. Latin America Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Disease Diagnosis
      • 7.2.1.2. Drug Discovery and Development
      • 7.2.1.3. Others
  • 7.3. Latin America Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Research Laboratories
      • 7.3.1.3. Diagnostic Laboratories
      • 7.3.1.4. Others
  • 7.4. Latin America Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 7.4.1.2. Brazil Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 7.4.1.3. Brazil Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 7.4.1.4. Mexico Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 7.4.1.5. Mexico Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 7.4.1.6. Mexico Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 7.4.1.7. Argentina Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 7.4.1.8. Argentina Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 7.4.1.9. Argentina Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 7.4.1.10. Rest of Latin America Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 7.4.1.11. Rest of Latin America Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 7.4.1.12. Rest of Latin America Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Anatomic Pathology Market Outlook, 2019 - 2032

  • 8.1. Middle East & Africa Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Anatomic Pathology Instruments
      • 8.1.1.2. Anatomic Pathology Consumables
      • 8.1.1.3. Anatomic Pathology Services
  • 8.2. Middle East & Africa Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Disease Diagnosis
      • 8.2.1.2. Drug Discovery and Development
      • 8.2.1.3. Others
  • 8.3. Middle East & Africa Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Research Laboratories
      • 8.3.1.3. Diagnostic Laboratories
      • 8.3.1.4. Others
  • 8.4. Middle East & Africa Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 8.4.1.2. GCC Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.3. GCC Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.4. South Africa Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 8.4.1.5. South Africa Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.6. South Africa Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.7. Egypt Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 8.4.1.8. Egypt Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.9. Egypt Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.10. Nigeria Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 8.4.1.11. Nigeria Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.12. Nigeria Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.13. Rest of Middle East & Africa Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 - 2032
      • 8.4.1.14. Rest of Middle East & Africa Anatomic Pathology Market by Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.15. Rest of Middle East & Africa Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 - 2032
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Market Share Analysis, 2025
  • 9.2. Competitive Dashboard
  • 9.3. Company Profiles
    • 9.3.1. BioGenex
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Product and Service Portfolio
      • 9.3.1.3. Financial Overview
      • 9.3.1.4. Business Strategies and Development
    • 9.3.2. Cardinal Health, Inc.
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Product and Service Portfolio
      • 9.3.2.3. Financial Overview
      • 9.3.2.4. Business Strategies and Development
    • 9.3.3. Sakura Finetek USA, Inc.
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Product and Service Portfolio
      • 9.3.3.3. Financial Overview
      • 9.3.3.4. Business Strategies and Development
    • 9.3.4. Quest Diagnostics Incorporated
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Product and Service Portfolio
      • 9.3.4.3. Financial Overview
      • 9.3.4.4. Business Strategies and Development
    • 9.3.5. Agilent Technologies
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Product and Service Portfolio
      • 9.3.5.3. Financial Overview
      • 9.3.5.4. Business Strategies and Development
    • 9.3.6. Bio SB
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Product and Service Portfolio
      • 9.3.6.3. Financial Overview
      • 9.3.6.4. Business Strategies and Development
    • 9.3.7. F. Hoffmann-La Roche AG
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Product and Service Portfolio
      • 9.3.7.3. Financial Overview
      • 9.3.7.4. Business Strategies and Development
    • 9.3.8. NeoGenomics
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Product and Service Portfolio
      • 9.3.8.3. Financial Overview
      • 9.3.8.4. Business Strategies and Development
    • 9.3.9. Laboratory Corporation of America Holdings
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Product and Service Portfolio
      • 9.3.9.3. Financial Overview
      • 9.3.9.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations